BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2834028)

  • 1. [Use of anti-ferritin antibody in the diagnosis and treatment of hepatocellular carcinoma].
    Liu KD
    Zhonghua Yi Xue Za Zhi; 1987 Nov; 67(11):621. PubMed ID: 2834028
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase I-II study of radiolabeled antibody integrated in the treatment of primary hepatic malignancies.
    Order SE; Klein JL; Ettinger D; Alderson P; Siegelman S; Leichner P
    Int J Radiat Oncol Biol Phys; 1980 Jun; 6(6):703-10. PubMed ID: 6256319
    [No Abstract]   [Full Text] [Related]  

  • 3. Dosimetry and treatment planning in radioimmunotherapy.
    Leichner PK; Yang NC; Wessels BW; Hawkins WG; Order SE; Klein JL
    Front Radiat Ther Oncol; 1990; 24():109-20; discussion 121-2. PubMed ID: 2160407
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor imaging and targeting therapy for hepatocellular carcinoma. Preliminary results of experimental and clinical studies.
    Tang ZY; Lui KD; Guo YD; Ma ZC; Yu D; Yu ZY; Boa YM; Lu JZ; Lin ZY; Yu YQ
    Chin Med J (Engl); 1986 Nov; 99(11):855-60. PubMed ID: 3034515
    [No Abstract]   [Full Text] [Related]  

  • 5. Computed tomography assisted volumetric analysis of primary liver tumor as a measure of response to therapy.
    Ettinger DS; Leichner PK; Siegelman SS; Fishman EK; Klein JL; Order SE
    Am J Clin Oncol; 1985 Oct; 8(5):413-8. PubMed ID: 2998178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of radioiodinated antibody to alpha-fetoprotein in hepatoma transplanted in rats and a case report of alpha-fetoprotein antibody treatment of a hepatoma patient.
    Koji T; Ishii N; Munehisa T; Kusumoto Y; Nakamura S; Tamenishi A; Hara A; Kobayashi K; Tsukada Y; Nishi S; Hirai H
    Cancer Res; 1980 Aug; 40(8 Pt 2):3013-5. PubMed ID: 6156759
    [No Abstract]   [Full Text] [Related]  

  • 7. [Targeting study of human hepatocellular carcinoma (HCC) using human HCC model in nude mice].
    Liu KD
    Zhonghua Zhong Liu Za Zhi; 1988 Nov; 10(6):414-6. PubMed ID: 2855054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiferritin immunoglobulin therapy for treatment of hepatoma.
    Held J; McLaughlin P
    Oncol Nurs Forum; 1987; 14(5):27-31. PubMed ID: 2821514
    [No Abstract]   [Full Text] [Related]  

  • 9. [Scintigraphic evaluation of non-surgical therapy of hepatoma].
    Odano I; Nishihara M; Soga K; Kimura M; Sakai K
    Rinsho Hoshasen; 1984 Dec; 29(13):1535-6. PubMed ID: 6099439
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin. Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion.
    Fan Z; Tang Z; Liu K; Zhou D; Lu J; Yuan A; Zhao H
    J Cancer Res Clin Oncol; 1992; 118(5):371-6. PubMed ID: 1316355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of N-isopropyl-p-[123I]iodoamphetamine and [99mTc]hexamethyl-propyleneamine oxime in metastatic hepatocellular carcinoma.
    Morita K; Ono S; Fukunaga M; Otsuka N; Nagai K; Watanabe A; Ohtsuka R; Ishii R; Ohumi T; Hirano Y
    J Nucl Med; 1988 Aug; 29(8):1460-2. PubMed ID: 2841433
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiferritin immunoglobulin therapy for treatment of hepatoma.
    Bucholtz JD; Powers G; Wall S
    Oncol Nurs Forum; 1988; 15(2):133-4. PubMed ID: 2451814
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of cell surface localizing antihepatoma antibody for tumor imaging and therapy with drug-linked antibody.
    Ghose T; Tai J; Guclu A; Norvell ST; Blair AH; Aquino J
    Transplant Proc; 1980 Mar; 12(1):192-4. PubMed ID: 6245488
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiferritin IgG antibody for isotopic cancer therapy.
    Order SE; Klein JL; Leichner PK
    Oncology; 1981; 38(3):154-60. PubMed ID: 6259569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of antineoplastic solution in transcatheter hepatic arterial embolization].
    Tsuda M; Sato M; Kawabata M; Shirai S; Tanaka K; Terada M; Shioyama Y; Maeda M; Kishi K; Suwa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jul; 47(7):995-7. PubMed ID: 2821482
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radioimmunoimaging of hepatic tumors with 131I labeled polyclonal antibody against alpha-fetoprotein (AFP)].
    Koizumi K; Aburano T; Yokoyama K; Watanabe N; Kawabata S; Shuke N; Mukai K; Tonami N; Hisada K; Tanaka N
    Kaku Igaku; 1986 Apr; 23(4):397-401. PubMed ID: 2426486
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of isotopic immunoglobulin in therapy.
    Order SE; Klein JL; Ettinger D; Alderson P; Siegelman S; Leichner P
    Cancer Res; 1980 Aug; 40(8 Pt 2):3001-7. PubMed ID: 6249495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness of a combined gammagraphic study with Tc-99 colloid and gallium-67 citrate in the diagnosis of hepatocellular carcinoma in hepatic cirrhosis].
    Barajas Martínez JM; Poves Martínez E; Bittini Copano AL; Domínguez Montero PL; Loeches Prado N; Jiménez Jaén C; Martínez Pueyo ML; Almoguera Arias I
    Rev Esp Enferm Apar Dig; 1987 Aug; 72(2):113-5. PubMed ID: 2821589
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatocellular carcinoma and monoclonal gammapathy. Apropos of 3 cases].
    del Palacio Pérez-Medel A; Herrero Huerta F; Vicente Rañada M; Larrumbe Labalde S; Martin Scapa MA; Martínez Tello F; Schuller Pérez A
    Rev Clin Esp; 1979 Feb; 152(3):243-7. PubMed ID: 220683
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent progress in the treatment of hepatocellular carcinoma.
    Roh MS
    Curr Opin Oncol; 1990 Aug; 2(4):725-30. PubMed ID: 1965691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.